528598-90-5Relevant articles and documents
New Colchicine-Derived Triazoles and Their Influence on Cytotoxicity and Microtubule Morphology
Thomopoulou, Persefoni,Sachs, Julia,Teusch, Nicole,Mariappan, Aruljothi,Gopalakrishnan, Jay,Schmalz, Hans-Günther
supporting information, p. 188 - 191 (2016/03/01)
A series of new colchicinoids with a variable triazole unit at C-7 was synthesized through Cu(I)-catalyzed 1,3-dipolar cycloaddition (click-chemistry) of a colchicine-derived azide with various alkynes and the cytotoxicity against THP-1 and Jurkat cancer cell lines was used for structural optimization. Three particularly active compounds (IC50 ≤ 5 nM) were additionally investigated with respect to their efficacy against relevant solid tumor cell lines (HeLa, A549, and SK MES 1). Besides distorting the microtubule morphology by tubulin depolymerization, one compound also exhibited a pronounced centrosome declustering effect in triple negative breast cancer cells (MDA-MB-231) and nonsmall cell lung cancer cells (H1975).
Partial hydrogenation of alkynes to cis-olefins by using a novel Pd 0-polyethyleneimine catalyst
Sajiki, Hironao,Mori, Shigeki,Ohkubo, Tomoyuki,Ikawa, Takashi,Kume, Akira,Maegawa, Tomohiro,Monguchi, Yasunari
supporting information; experimental part, p. 5109 - 5111 (2009/05/07)
The creation and application of a new Pd0-polyethyleneimine complex catalyst (Pd0-PEI) was investigated. The 55 Pd 0-PEI catalyst was prepared by introduction of Pd(OAc)2 directly in the MeOH solution of deaerated PEI under Ar atmosphere. Reactions were carried out using 10 weight % versus substrate of 5% Pd0-PEI in 2mL solvent under H2 atmosphere at room temperature. The generality of the process was shown by disubstituting alkynes. Even for the substrate bearing a conjugated ketone on the alkyne, the serious over-reduction was not observed while significant cistrans isomerization of methyl styryl ketone accompanied the partial hydrogenation on the basis of keto-enol tautomerism. Pd0-PEI catalyst is also applicable to the partial hydrogenation of monosubstituted alkynes to monosubstituted olefins.
Further studies on 2,4-diamino-5-(2′,5′-disubstituted benzyl)pyrimidines as potent and selective inhibitors of dihydrofolate reductases from three major opportunistic pathogens of AIDS
Rosowsky, Andre,Forsch, Ronald A.,Queener, Sherry F.
, p. 1726 - 1736 (2007/10/03)
As part of an ongoing effort to discover novel small-molecule antifolates combining the enzyme-binding species selectivity of trimethoprim (TMP) with the potency of piritrexim (PTX), 10 previously unreported 2,4-diamino-5-(2′-methoxy-5′-substituted)benzylpyrimidines (2-11) containing a carboxyl group at the distal end of the 5′-substituent were synthesized and tested as inhibitors of dihydrofolate reductase (DHFR) from Pneumocystis carinii (Pc), Toxoplasma gondii (Tg), and Mycobacterium avium (Ma), three of the opportunistic pathogens frequently responsible for life-threatening illness in people with impaired immune systems as a result of HIV infection or immunosuppressive chemotherapy. The selectivity index of DHFR inhibition was evaluated by comparing the potency of each compound against the parasite enzymes with its potency against rat liver DHFR. 2,4-Diamino-5-[5′-(5-carboxy-1-pentynyl)-2′- methoxybenzyl]pyrimidine (3) inhibited Pc DHFR with a selectivity index of 79 and was 430 times more potent than TMP. 2,4-Diamino-5-[5′-(4-carboxy-1-butynyl)-2′-methoxybenzyl] pyrimidine (2), with one less carbon than 3 in the side chain, had a selectivity index of 910 against Ma DHFR and was 43 times more potent than TMP. 2,4-Diamino-5-[5′-(5-carboxypentyl)-2′-methoxybenzyl]pyri midine (6) had a selectivity index of 490 against Tg DHFR and was 320 times more potent than TMP. 2,4-Diamino-5-[5′-(6-carboxy-1-hexynyl)-2′-methoxybenzyl] pyrimidine (4), with one more carbon than 3, was less potent against all three of the parasite enzymes than either 3 or 6 and also had a lower selectivity index than 3 against the Pc enzyme. However, 4 was the only member of the series with a selectivity index of >300 against both Tg and Ma DHFR. Given that PTX is at least 10 times more potent against rat DHFR than against P. carinii or T. gondii DHFR and that the selectivity index of several of the compounds matches or exceeds that of TMP as well as PTX, our results suggest that it may be possible to develop clinically useful nonclassical antifolates that are both potent and selective against the major opportunistic pathogens of AIDS.
